Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and Leukemia Group B Trial 9732.
- Citation:
- J Clin Oncol vol 23 (16) 3752-9
- Year:
- 2005
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Harvey B Niell
- Authors:
- Harvey B Niell James E Herndon Antonius A Miller Dorothy M Watson Alan B Sandler Karen Kelly Randolph S Marks Micheal C Perry Rafat H Ansari Grefory Otterson John Ellerton Everett E Vokes Mark R Green
- Networks:
- Study
- Alliance-9732
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- Keywords:
- Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Small Cell, Cisplatin, Disease Progression, Etoposide, Female, Granulocyte Colony-Stimulating Factor, Humans, Lung Neoplasms, Male, Middle Aged, Neoplasm Staging, Paclitaxel, Prospective Studies, Recombinant Proteins, Survival Rate, Time Factors